期刊文献+

复方甘草酸苷对溃疡性结肠炎大鼠结肠组织SOD、MDA、MPO酶的影响 被引量:5

Effect of Compound Glycyrrhizin on Activities of SOD、 MDA and MPO in TNBS-Induced Colitis Rats
下载PDF
导出
摘要 目的探讨复方甘草酸苷对溃疡性结肠炎(UC)大鼠的治疗作用。方法将50只SD大鼠随机分成正常对照组(10只,不做任何处理)和模型组[40只,采用2,4,6-三硝基苯磺酸(TNBS)法复制UC大鼠模型]。造模3 d后,模型组又随机分成模型组对照组(0.9%氯化钠溶液)、复方甘草酸苷低、高剂量组(剂量分别为12.5,50 mg.kg-1.d-1)和阳性对照组(300 mg.kg-1.d-1美沙拉嗪溶液)。各组按设计剂量灌胃给药10 d后,取结肠组织观察病变程度并评分,并测定超氧化物歧化酶(SOD)、丙二醛(MDA)、髓过氧化物酶(MPO)的含量。结果各治疗组肠炎病变评分和MDA含量与模型对照组比较显著下降(P<0.05),SOD、MPO未见统计学差异。结论复方甘草酸苷对UC的治疗作用可能与减轻或阻断组织的脂质过氧化反应及改善组织的病变程度有关。 Objective To study the protective effects of compound glycyrrhizin on inflammatory injury in ulcerative colitis rats. Methods Fifty rats were divided into normal control group (n = 10, untreated) and model group [ n = 40, colitis model rats were induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS) ]. After 3 d, model group was divided into 4 groups: model control group (0.9% sodium chloride solution), low-dose compound glycyrrhizin group (12.5 mg. kg-1 . d-1) , high-dose compound glycyrrhizin group (50 mg. kg-1. d-1 ), and positive group (300 mg. kg-1. d-1 mesalazine solution). According to each design dose to gavage after administration of 10 d, colonic mucosa was observed and histopathological scored, and the content of superoxide dismutase (SOD) ] malondialdehyde (MDA) and myeloperoxidase (MPO) was determined. Results In the treatment groups, the histopathological score and the content of MDA had significantly decreased compared with those of the model group ( P 〈 0.05 ), whereas the activity of SOD and MPO had no significant changes. Conclusion Compound glycyrrhizin have protective effects on ulcerative colitis, which may be due to reduction or blocking of the lipid peroxidation of tissue and improvement of histopathological changes.
出处 《今日药学》 CAS 2012年第5期274-276,共3页 Pharmacy Today
关键词 复方甘草酸苷 溃疡性结肠炎 超氧化物歧化酶 丙二醛 髓过氧化物酶 compound glycyrrhizin ulcerative colitis superoxide dismutase malondialdehyde myeloperoxidase
  • 相关文献

参考文献11

二级参考文献59

共引文献310

同被引文献52

  • 1宋卫兵,吕永慧,李亚南,肖丽萍,余新沛,刘岗,王媛媛,张小兰,李鹰飞.肠炎清通过抑制NF-κB活性对大鼠肠黏膜起抗炎作用[J].南方医科大学学报,2009,29(7):1431-1434. 被引量:5
  • 2刘一品,李延青.核因子-κB的表达在溃疡性结肠炎发病机制中的意义[J].胃肠病学,2006,11(2):103-106. 被引量:33
  • 3陈英群,董福轮,马贵同.三硝基苯磺酸诱导大鼠溃疡性结肠炎的实验研究[J].同济大学学报(医学版),2006,27(6):31-33. 被引量:26
  • 4韩涛,谭丹,张毅,薛新丽,殷胜骏.中药复方治疗溃疡性结肠炎研究探要[J].中国实验方剂学杂志,2007,13(3):69-71. 被引量:14
  • 5Baltina LA. Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine [ J ]. Curr Med Chem, 2003, 10 (2) : 155-171.
  • 6Luk HH, Ko JK, Fung HS, et al. Delineation of the protective action of zinc sulfate on ulcerative colitis in rats [J]. Eur J Pharmacol, 2002, 443 (1-3): 197-204.
  • 7Dundar E, Olgun EG, Isiksoy S, et al. The effects of intra- rectal and intra-peritoneal application of Origanum onites L. essential oil on 2, 4, 6-trinitrobenzenesulfonic acid- induced colitis in the rat [ J ]. Exp Toxicol Pathol, 2008, 59 (6): 399-408.
  • 8Xavier R J, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease [ J ]. Nature, 2007, 448 (7152) : 427-434.
  • 9Andresen L, Jcrgensen VL, Perner A, et al. Activation of nuclear factor kappaB in colonic mueosa from patients with collagenous and ulcerative colitis[ J ]. Gut, 2005,54 (4) : 503 -509.
  • 10Matsuda R, Koide T, Tokoro C, et al. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid na've ulcerative colitis during active and quiescent disease[ J]. Inflamm Bowel Dis, 2009, 15 (3) : 328 -334.

引证文献5

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部